1223P First-line lenvatinib (Len) + pembrolizumab (Pembro) + chemotherapy (Chemo) vs chemo in advanced/metastatic gastroesophageal adenocarcinoma: LEAP-015 safety run-in
暂无分享,去创建一个
E. Van Cutsem | Y. Janjigian | L. Wyrwicz | C. Shih | I. Ben-Aharon | F. Ghiringhelli | S. Qin | J. Xu | K. Shitara | A. Hubert | P. Bhagia | D. Cohen | C. Rojas | A. Wang | M. Miller | J. Tabernero | L. Bai | D.A. Acosta Eyzaguirre | H. Araya Moya | P.E. Yanez Weber